terlipressin has been researched along with Respiratory Insufficiency in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curry, MP; Jamil, K; Pappas, SC; Reddy, KR; Sanyal, A; Vargas, H; Wong, F | 1 |
| Curry, MP; Escalante, S; Frederick, RT; Gonzalez, SA; Jamil, K; Lim, N; Mayo, MJ; Mumtaz, K; Pappas, SC; Porayko, MK; Reddy, KR; Rubin, RA; Sanyal, AJ; Sharma, P; Simonetto, DA; Wong, F | 1 |
2 trial(s) available for terlipressin and Respiratory Insufficiency
| Article | Year |
|---|---|
Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure.
Topics: Acute-On-Chronic Liver Failure; Albumins; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Respiratory Insufficiency; Terlipressin; Vasoconstrictor Agents | 2022 |
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
Topics: Albumins; Combined Modality Therapy; Double-Blind Method; Female; Hepatorenal Syndrome; Humans; Infusions, Intravenous; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Renal Replacement Therapy; Respiratory Insufficiency; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2021 |